ASTRAZENECA GRANTED PARTIAL SHIELD AGAINST SIDE-EFFECT CLAIMS IN EU COVID VACCINE DEAL -EU SOURCE
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,433 GBX | +0.59% | +2.12% | +17.21% |
04:02pm | AstraZeneca: licensing agreement signed with Nona Biosciences | CF |
06:21am | HBM Holdings Unit, AstraZeneca Sign License, Option Agreement for Targeted Cancer Treatment; Shares Rise 16% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.21% | 244B | |
+38.21% | 723B | |
+34.48% | 595B | |
-2.78% | 369B | |
+20.62% | 332B | |
+2.58% | 282B | |
+9.61% | 208B | |
-4.58% | 205B | |
+0.43% | 168B | |
+7.30% | 166B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- Astrazeneca Granted Partial Shield Against Side-Effect Claims In Eu Covid Vaccine Deal -Eu Source